Investment platform
Русский
Беларускі
Español
Curis, Inc.
Sell1.5578
Spread0.0844
Buy1.6422

Trade Curis, Inc. - CRIS stock price

Sell1.5578
Spread0.0844
Buy1.6422
1m
5m
15m
30m
1H
4H
1D
1W
History
Open on platform
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation that is in Phase Ia/Ib clinical trial in patients with solid tumors. The company''s pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma and solid tumors; CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas; and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. The company was incorporated in 2000 and is headquartered in Lexington, Massachusetts.

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Download on the App Store Get it on Google Play None Explore platform Show QR
Articles
Chart of the week: TON, IP, XDC, CRO and TRX altcoins could weather the storm
Read more
Bitpanda eyes market expansion as it hits record profitability
Read more
Interview | WAX and Tether co-founder on the impact of the GENIUS Act on the tokenization of the global financial markets
Read more
Will IMX price withstand the upcoming 1.3% token unlock?
Read more
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

CRIS price history

  • Last 7 days
  • Last 30 days
  • Last Year
  • Last 2 Years
  • Maximum Period
  • Daily
  • Weekly
  • Monthly
Date Close Change Chg% Open Min. Max.
2022-09-30 1.5578 0.0000 0.00 1.5578 1.5279 1.6278
2022-09-30 1.5978 0.0300 1.91 1.5678 1.5279 1.6278
2022-09-30 1.6278 -0.0099 -0.60 1.6377 1.6278 1.6677
2022-09-30 1.6777 -0.0999 -5.62 1.7776 1.6777 1.7776
2022-09-30 1.6977 -0.1198 -6.59 1.8175 1.6977 1.8175
2022-09-30 1.7875 -0.0100 -0.56 1.7975 1.7676 1.8375
2022-09-30 1.7975 0.0499 2.86 1.7476 1.7476 1.8275
2022-09-30 1.7576 -0.0299 -1.67 1.7875 1.7276 1.8175
2022-09-30 1.7676 -0.0299 -1.66 1.7975 1.7276 1.7976
2022-09-30 1.7876 0.0999 5.92 1.6877 1.6477 1.8375
2022-09-30 1.6777 -0.1198 -6.66 1.7975 1.6777 1.7975
2022-09-30 1.7376 -0.0799 -4.40 1.8175 1.7276 1.8275
2022-09-30 1.8075 0.0200 1.12 1.7875 1.7875 1.8775
2022-09-30 1.7576 -0.0799 -4.35 1.8375 1.7576 1.8375
2022-09-30 1.7776 0.0200 1.14 1.7576 1.7476 1.8375
Go help.dzengi.com
Dzengi.com Exchange
Trade BTC & tokenized stocks